- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04707612
VDR SNPs & 25OHD Correlated With Dyslipidemia
January 12, 2021 updated by: Zhou Ji-Chang, Shenzhen Center for Chronic Disease Control
The project was aimed to explore the associations of single nucleotide polymorphisms (SNPs) of vitamin D receptor gene with specific circulating lipids in adult Chinese.
The circulating 25-hydroxyvitamin D concentration was also tested to explore its interactions with SNPs in the associations.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
1987
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Shenzhen, Guangdong, China, 518020
- Shenzhen Center for Chronic Disease Control
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 81 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Adult volunteers visiting a health examination center in Shenzhen city of Guangdong province, China were recruited.
A total of 1,987 adults were included in the analysis, aged from 20 to 81 years old. Among them, there were 1,124 females aged 39 (31 - 49) years old and 863 males aged 36 (30 - 44) years old.
Description
Inclusion Criteria:
- 1) ≥ 20 years old Han Chinese;
- 2) living in Shenzhen for > 2 years;
- 3) free of liver diseases, renal diseases, and any cancers in the past 6 months; and
- 4) not in pregnancy for women.
Exclusion Criteria:
- 1) had severe organic diseases,
- 2) had acute infection symptoms, allergic diseases, and malignant tumors,
- 3) had a family history of genetic diseases,
- 4) took VD supplements in the past 6 months,
- 5) took medicines to control lipid levels within 12 hours, or
- 6) took diuretics, did strenuous exercise, or overate within 24 hours before the test.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SNPs of VDR
Time Frame: 6 months
|
Polymorphisms of vitamin D receptor gene: Cdx2, Fok1, Apa1, and Taq1
|
6 months
|
lipid profiles
Time Frame: 6 months
|
Serum concentrations of TG, TC, LDLC, and HDLC
|
6 months
|
25OHD
Time Frame: 6 months
|
Plasma 25-hydroxyvitamin D concentration
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2013
Primary Completion (Actual)
January 31, 2014
Study Completion (Actual)
October 31, 2016
Study Registration Dates
First Submitted
January 10, 2021
First Submitted That Met QC Criteria
January 12, 2021
First Posted (Actual)
January 13, 2021
Study Record Updates
Last Update Posted (Actual)
January 13, 2021
Last Update Submitted That Met QC Criteria
January 12, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- QLS2015
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dyslipidemias
-
IlDong Pharmaceutical Co LtdCompletedMixed DyslipidemiasKorea, Republic of
-
Orient Pharma Co., Ltd.CompletedPrimary Hypercholesterolemia | Mixed DyslipidemiasTaiwan, Australia, New Zealand
-
University of PaviaFoundation IRCCS San Matteo HospitalRecruiting
-
Çankırı Karatekin UniversityHacettepe UniversityRecruiting
-
Daewoong Pharmaceutical Co. LTD.RecruitingDyslipidemiasKorea, Republic of
-
AstraZenecaParexelRecruitingDyslipidemiaUnited States, United Kingdom
-
Jiangxi University of Traditional Chinese MedicineNot yet recruiting
-
Mackay Memorial HospitalAmgenRecruiting
-
EMSRecruiting
-
Daiichi SankyoDaiichi Sankyo Korea Co., Ltd.Active, not recruiting
Clinical Trials on No intervention.
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of PittsburghCompletedChronic Low Back PainUnited States